Skip to main content
PMC home page
Epidemiology and Infection logoLink to Epidemiology and Infection
. 1992 Dec;109(3):473–481. doi: 10.1017/s0950268800050469

Transferable high-level trimethoprim resistance among isolates of Escherichia coli from urinary tract infections in Ontario, Canada.

N Harnett 1
PMCID: PMC2271948  PMID: 1468531

Abstract

Of 1171 isolates of Escherichia coli isolated from urine samples at the Public Health Laboratory, Toronto, Ontario, Canada, between May 1990 and December 1991, 120 (10.3%) were resistant to trimethoprim (TMP), cotrimoxazole (TMP/SMX), sulfamethoxazole (SMX) and other antimicrobial agents; 110 of the 120 isolates (91.7%) were resistant to four or more agents. The majority of resistant isolates (91.7%) exhibited high-level resistance (MIC > 1000 mg/L) to TMP. The MIC of TMP/SMX for all 120 isolates was > 2.0/38.0 mg/L and for SMX > 1024 mg/L. High-level resistances were also present among the beta-lactam antimicrobials with MICs ranging from 16- > 256 mg/L. Forty-three of 120 TMP-resistant (35.8%) isolates conjugally transferred TMP-resistance to E. coli K-12. Co-transfer of several other resistances was observed. SMX cotransferred from 86% of the 43 donors and beta-lactams together with SMX cotransferred from 70%. Nalidixic acid resistance was present among 22 (18.3%) of the 120 resistant isolates, however, nalidixic acid resistance was not transferred to E. coli K-12.

Full text

PDF
477

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cavalieri S. J., Snyder I. S. Effect of Escherichia coli alpha-hemolysin on human peripheral leukocyte viability in vitro. Infect Immun. 1982 May;36(2):455–461. doi: 10.1128/iai.36.2.455-461.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Cullen M. E., Wyke A. W., Kuroda R., Fisher L. M. Cloning and characterization of a DNA gyrase A gene from Escherichia coli that confers clinical resistance to 4-quinolones. Antimicrob Agents Chemother. 1989 Jun;33(6):886–894. doi: 10.1128/aac.33.6.886. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Harnett N. Antimicrobial susceptibilities of Shigella species isolated in Ontario in 1990. Can Dis Wkly Rep. 1991 Dec 14;17(50):275–277. [PubMed] [Google Scholar]
  4. Harnett N. High level resistance to trimethoprim, cotrimoxazole and other antimicrobial agents among clinical isolates of Shigella species in Ontario, Canada--an update. Epidemiol Infect. 1992 Dec;109(3):463–472. doi: 10.1017/s0950268800050457. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Harnett N., McLeod S., AuYong Y., Krishnan C. Increasing incidence of resistance among shigellae to trimethoprim. Lancet. 1991 Mar 9;337(8741):622–622. doi: 10.1016/0140-6736(91)91694-p. [DOI] [PubMed] [Google Scholar]
  6. Heikkilä E., Renkonen O. V., Sunila R., Uurasmaa P., Huovinen P. The emergence and mechanisms of trimethoprim resistance in Escherichia coli isolated from outpatients in Finland. J Antimicrob Chemother. 1990 Feb;25(2):275–283. doi: 10.1093/jac/25.2.275. [DOI] [PubMed] [Google Scholar]
  7. Heikkilä E., Siitonen A., Jahkola M., Fling M., Sundström L., Huovinen P. Increase of trimethoprim resistance among Shigella species, 1975-1988: analysis of resistance mechanisms. J Infect Dis. 1990 Jun;161(6):1242–1248. doi: 10.1093/infdis/161.6.1242. [DOI] [PubMed] [Google Scholar]
  8. Heikkilä E., Sundström L., Huovinen P. Trimethoprim resistance in Escherichia coli isolates from a geriatric unit. Antimicrob Agents Chemother. 1990 Oct;34(10):2013–2015. doi: 10.1128/aac.34.10.2013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Knothe H., Shah P., Krcmery V., Antal M., Mitsuhashi S. Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens. Infection. 1983 Nov-Dec;11(6):315–317. doi: 10.1007/BF01641355. [DOI] [PubMed] [Google Scholar]
  10. Lamikanra A., Ndep R. B. Trimethoprim resistance in urinary tract pathogens in two Nigerian hospitals. J Antimicrob Chemother. 1989 Jan;23(1):151–154. doi: 10.1093/jac/23.1.151. [DOI] [PubMed] [Google Scholar]
  11. Mayer K. H., Fling M. E., Hopkins J. D., O'Brien T. F. Trimethoprim resistance in multiple genera of Enterobacteriaceae at a U.S. hospital: spread of the type II dihydrofolate reductase gene by a single plasmid. J Infect Dis. 1985 May;151(5):783–789. doi: 10.1093/infdis/151.5.783. [DOI] [PubMed] [Google Scholar]
  12. Murray B. E., Alvarado T., Kim K. H., Vorachit M., Jayanetra P., Levine M. M., Prenzel I., Fling M., Elwell L., McCracken G. H. Increasing resistance to trimethoprim-sulfamethoxazole among isolates of Escherichia coli in developing countries. J Infect Dis. 1985 Dec;152(6):1107–1113. doi: 10.1093/infdis/152.6.1107. [DOI] [PubMed] [Google Scholar]
  13. Nandivada L. S., Amyes S. G. Plasmid-mediated beta-lactam resistance in pathogenic gram-negative bacteria isolated in south India. J Antimicrob Chemother. 1990 Aug;26(2):279–290. doi: 10.1093/jac/26.2.279. [DOI] [PubMed] [Google Scholar]
  14. Ronald A. R., Turck M., Petersdorf R. G. A critical evaluation of nalidixic acid in urinary-tract infections. N Engl J Med. 1966 Nov 17;275(20):1081–1089. doi: 10.1056/NEJM196611172752001. [DOI] [PubMed] [Google Scholar]
  15. Tauxe R. V., Puhr N. D., Wells J. G., Hargrett-Bean N., Blake P. A. Antimicrobial resistance of Shigella isolates in the USA: the importance of international travelers. J Infect Dis. 1990 Nov;162(5):1107–1111. doi: 10.1093/infdis/162.5.1107. [DOI] [PubMed] [Google Scholar]
  16. Trimethoprim--resistant coliforms. Lancet. 1977 Oct 29;2(8044):926–926. [PubMed] [Google Scholar]
  17. Tsakris A., Johnson A. P., George R. C., Mehtar S., Vatopoulos A. C. Distribution and transferability of plasmids encoding trimethoprim resistance in urinary pathogens from Greece. J Med Microbiol. 1991 Mar;34(3):153–157. doi: 10.1099/00222615-34-3-153. [DOI] [PubMed] [Google Scholar]
  18. Waalwijk C., MacLaren D. M., de Graaff J. In vivo function of hemolysin in the nephropathogenicity of Escherichia coli. Infect Immun. 1983 Oct;42(1):245–249. doi: 10.1128/iai.42.1.245-249.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Waalwijk C., van den Bosch J. F., MacLaren D. M., de Graaff J. Hemolysin plasmid coding for the virulence of a nephropathogenic Escherichia coli strain. Infect Immun. 1982 Jan;35(1):32–37. doi: 10.1128/iai.35.1.32-37.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Welch R. A., Dellinger E. P., Minshew B., Falkow S. Haemolysin contributes to virulence of extra-intestinal E. coli infections. Nature. 1981 Dec 17;294(5842):665–667. doi: 10.1038/294665a0. [DOI] [PubMed] [Google Scholar]
  21. Young H. K., Jesudason M. V., Koshi G., Amyes S. G. Trimethoprim resistance amongst urinary pathogens in south India. J Antimicrob Chemother. 1986 May;17(5):615–621. doi: 10.1093/jac/17.5.615. [DOI] [PubMed] [Google Scholar]
  22. Young H. K., Jesudason M. V., Koshi G., Amyes S. G. Unusual expression of new low-level-trimethoprim-resistance plasmids. J Clin Microbiol. 1986 Jul;24(1):61–64. doi: 10.1128/jcm.24.1.61-64.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Epidemiology and Infection are provided here courtesy of Cambridge University Press

RESOURCES